Glenmark Pharmaceuticals has informed that the board of directors of the company, at its operation committee meeting held on March 16, 2012, allotted 20,450 shares to the employees of the company on exercise of options granted to them pursuant to ESOS 2003
The above information is part of company’s filing submitted to the BSE.